Aerospace & Defense
Axon delivered 35% revenue growth and swung to an operating profit in Q2 FY2026 on the back of TASER 10 and counter-drone equipment sales, though net income fell as a prior-year tax benefit did not repeat.
Key risk: Dependence on Government and Law Enforcement Budgets
A substantial portion of Axon's revenue comes from public sector customers, whose purchasing decisions are influenced by government budget cycles and policy shifts. Cuts in law enforcement funding could materially reduce demand for TASER devices and related services.
Other Aerospace & Defense companies